Travis Alan Coy - Jan 1, 2025 Form 4 Insider Report for Immunocore Holdings plc (IMCR)

Role
Chief Financial Officer
Signature
/s/ Lily Hepworth, Attorney-in-Fact
Stock symbol
IMCR
Transactions as of
Jan 1, 2025
Transactions value $
$0
Form type
4
Date filed
1/3/2025, 04:08 PM
Previous filing
Jan 2, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMCR Employee Share Option (Right to Buy) Award $0 +274K $0.00 274K Jan 1, 2025 Ordinary Shares 274K $29.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option award shall vest on January 1, 2026, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.